Citigroup’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14K | Sell |
19,126
-46,721
| -71% | -$34.3K | ﹤0.01% | 4402 |
|
|
2025
Q1 | $65.8K | Sell |
65,847
-41,610
| -39% | -$41.6K | ﹤0.01% | 4032 |
|
|
2024
Q4 | $1.14M | Buy |
107,457
+39,679
| +59% | +$421K | ﹤0.01% | 2514 |
|
|
2024
Q3 | $895K | Buy |
67,778
+47,070
| +227% | +$622K | ﹤0.01% | 2637 |
|
|
2024
Q2 | $204K | Sell |
20,708
-47,750
| -70% | -$469K | ﹤0.01% | 3146 |
|
|
2024
Q1 | $941K | Buy |
68,458
+62,712
| +1,091% | +$862K | ﹤0.01% | 2414 |
|
|
2023
Q4 | $98K | Sell |
5,746
-8,670
| -60% | -$148K | ﹤0.01% | 3468 |
|
|
2023
Q3 | $203K | Buy |
+14,416
| New | +$203K | ﹤0.01% | 2975 |
|